These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 29956207)
1. Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack? Baffy G Adv Exp Med Biol; 2018; 1061():63-77. PubMed ID: 29956207 [TBL] [Abstract][Full Text] [Related]
2. Introduction. Wong CC; Yu J Adv Exp Med Biol; 2018; 1061():1-2. PubMed ID: 29956202 [TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. Streba LA; Vere CC; Rogoveanu I; Streba CT World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Noureddin M; Rinella ME Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. Perumpail RB; Wong RJ; Ahmed A; Harrison SA Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831 [TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. Li X; Wang X; Gao P Biomed Res Int; 2017; 2017():5202684. PubMed ID: 29379799 [TBL] [Abstract][Full Text] [Related]
9. Key features of the environment promoting liver cancer in the absence of cirrhosis. Zaki MYW; Mahdi AK; Patman GL; Whitehead A; Maurício JP; McCain MV; Televantou D; Abou-Beih S; Ramon-Gil E; Watson R; Cox C; Leslie J; Wilson C; Govaere O; Lunec J; Mann DA; Nakjang S; Oakley F; Shukla R; Anstee QM; Tiniakos D; Reeves HL Sci Rep; 2021 Aug; 11(1):16727. PubMed ID: 34408183 [TBL] [Abstract][Full Text] [Related]
10. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. Marengo A; Rosso C; Bugianesi E Annu Rev Med; 2016; 67():103-17. PubMed ID: 26473416 [TBL] [Abstract][Full Text] [Related]
11. NAFLD-related HCC. Banini BA; Sanyal AJ Adv Cancer Res; 2021; 149():143-169. PubMed ID: 33579423 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Torres DM; Harrison SA Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886 [TBL] [Abstract][Full Text] [Related]
13. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. Hessheimer AJ; Forner A; Varela M; Bruix J Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1239-44. PubMed ID: 20505515 [TBL] [Abstract][Full Text] [Related]
14. Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries. Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104 [TBL] [Abstract][Full Text] [Related]
15. NAFLD Related-HCC: The Relationship with Metabolic Disorders. Zhang X Adv Exp Med Biol; 2018; 1061():55-62. PubMed ID: 29956206 [TBL] [Abstract][Full Text] [Related]
16. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341 [TBL] [Abstract][Full Text] [Related]
17. Should we undertake surveillance for HCC in patients with NAFLD? Younes R; Bugianesi E J Hepatol; 2018 Feb; 68(2):326-334. PubMed ID: 29122695 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. Zhang C; Liu S; Yang M Front Endocrinol (Lausanne); 2021; 12():808526. PubMed ID: 35002979 [TBL] [Abstract][Full Text] [Related]